menu ☰
menu ˟

Baricitinib improves RA in patients unresponsive to methotrexate

16 Jul 2019
Baricitinib monotherapy improves disease control in many patients with rheumatoid arthritis who were did not respond to methotrexate, according to data published in Arthritis Care & Research.“Many patients and physicians prefer monotherapy trea...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.